Documente Academic
Documente Profesional
Documente Cultură
47
reaction atherosclerosis or coronary - to remove secretions
• Avoid hazardous *Shoulder artery disease To provide patent airway
activities when using -abduction
drug -adduction (anterior &
• Tell patient to avoid using posterior) *Routine fluid analysis
alcohol when under drug -horizontal flexion and - Indicates the amount and
therapy extension characteristic of pleural
• Tell patient to take drug -internal & external rotation fluid
exactly as prescribed and
not to stop abruptly
• Warn patient of physical *Elbow *AFB staining
and psychological -rotation for supination and - Test done to detect
dependence pronation Presence of TB
47
withdraw drug abruptly dorsiflexion -Is an effective test
after long-term use. -eversion & inversion primarily for determining
Withdrawal symptoms renal function.
may occur.
Coughing Deep Breathing *Prothrombin time
Exercise -measures the clotting
- Facilitate
ability of factors I,II,V,VII
*Lactulose expectoration of
and X.
secretion from the *Hepatitis B Surface
C- respiratory tract Antigen
Laxatives. Indicated for - Facilitate maximum -done to determine the
constipation lung expansion presence of heap b virus in
the blood in either an active
H- Splinting of the Affected or carrier state.
Relieves constipation, Site
decreases blood ammonia - Relieves the client *Hepatitis C Virus Test
concentration. from pain -is formerly a non A, non B
hepatitis. Transmitted
Assessment parameter of Changing Positions parenterally.
effectiveness. Frequently
Patient’s constipation is - Prevent from *Complete blood count
relieved pressure ulcers (CBC), also known as full
- Promote proper blood count (FBC) or full
E- body circulation blood exam (FBE) or blood
Lactulose 30cc IVTT Q4 panel
47
with lactose Abnormally high or low
• Diarrhea indicate counts may indicate the
overdose presence of many forms of
• To minimize sweet taste, disease, and hence blood
dilute in water or fruit counts are amongst the
juice or give with food most commonly performed
• Tell patient about adverse blood tests in medicine, as
reaction and to tell they can provide an
prescriber if more than 3 overview of a patient's
soft stools are passed. general health status.
• Store drug at room
temperature 30°C
*Serum Creatinine
K-
-is used along with a BUN
• Contraindicated in patient
(blood urea nitrogen) test to
on low-galactose diet
assess kidney function.
• Use cautiously in patient Both are frequently ordered
with DM because drug as part of a basic or
contain lactose, galactose, comprehensive metabolic
and other sugars. panel (BMP or CMP),
• Assess patient’s condition groups of tests that are
before starting therapy performed to evaluate the
and regularly thereafter to function of the body’s
monitor drug major organs.
effectiveness.
• Monitor patient’s
electrolyte in long term
use
• Be alert for adverse *Serum Potassium
reactions
47
• Don’t confuse lactulose -is ordered to check the
with lactose. potassium level of the
• Replace fluid loss client. To detect presence
• Diarrhea may indicate of hypo or hyperKalemia.
overdose To monitor potassium
• Store drug at room levels during health
temperature 30°C problems
Azithromycin Treatment
C- *Oxygen therapy
Antibiotic
> acute exacerbation of -is the administration of
COPD cause by. S. oxygen at a concentration
pneumonia of pressure greater than that
>AP cause by S. found in the environmental
pneumonia atmosphere. It is
particularly useful in
H – Client is free from treatment of hypoxemic
infection state and results in adequate
transport of oxygen by
E- 500 mg, IVTT, OD blood.
*Nasogastric intubation
C – Tell client to be alert of
adverse reactions -is a medical process
involving the insertion of a
K– plastic tube (nasogastric
tube, NG tube) through the
• Assess if patient is
nose, past the throat, and
hypersensitivity to drug
down into the stomach.
• Be alert for any adverse
47
reaction -the main use of a
• Assess patient’s nasogastric tube is for
infection before starting feeding and for
therapy administering drugs and
• Before giving first dose, other oral agents.
obtain specimen for
culture and sensitivity *Intravenous therapy or
tests IV therapy
• Instruct patient to take
drugs exactly as -is the giving of liquid
prescribed substances directly into a
• Tell patient to report vein.
adverse reaction -It’s purpose is to supply
• Don’t give with antacids fluid when client are unable
to take in an aequate
• Tell patient that drug can
volume of fluid by mouth.
be taken with or without
To provide glucose, the
foods
main fuel for metabolism.
Tell patient to avoid
To provide salts needed to
prolonge exposure to sun.
maintain electrolyte
balance
Furosemide
PNSS
C – Diuretics
PLR
• Actue pulmonary edema
• Edema Endotracheal Intubation
• Heart and chronic renal - Insertion of a hollow
impairment curved polyvinylchloride
• Hypertension tube through either the nose
Hypercalemia or the mouth into the
trachea accomplished by
H–
47
(-) crackels means of a bladed
(-) edema instrument/ laryngoscope
47
taking OTC drugs or
gerbil remedies
• Evaluate if patient is free
form edema.
Atropine Sulfate
C- Anticholinergics
• GIT disorder
• GU disorder
• Respiratory disorder
H-
Effectiveness
Patient is relive form
bradycardia
Decrease in secretions
E-
0.5 mg, IVTT, STAT
C–
Tell patient of Adverse
reactions
K–
• `Monitor VS. tachycardia
is a side effect that occurs
with large doses of
anticholinergics such as
atropine sulfate
47
• Assess urine output.
Urinary retention may
occur
• Check bowel sounds.
absence of bowel sounds
may indicate paralytic
ileus resulting from a
decrease GI motility.
• Raise side rails for client
who are confused and
debilitated. Atropine
sulfate could cause CNS
stimulation (Excitement
or confusion)
Aminoleban
C – Amino Acids
H–
Faster wound healing
Relieve from hepatic
encephalopathy
E - 1 satchet, BID
K–
• Contraindicated to
47
patient with severe renal
impairment and
abnormal amino acid
metabolism
• Use cautiously in patient
with severe acidosis,
CHF
Ertrapenem
C- Antibiotic
• Community acquired
pneumonia caused by
Steptococcus
Pneumoniae
• Complicated UTI
E - 1g, IVTT, OD
C-
Tell patient of Advrse drug
reaction
Tell patient to take drug as
prescribed
K–
47
penicillin, cephalosporin,
or other betalactam
hypersensitivity
• Monitor renal, hepatic,
and hematopoetic
function, during
prolonged therapy
• Inform patient of potential
adverse reactions and
urge him to notify
prescriber immediately
if they occur
• If allergic reaction occurs
stop drug immediately
and give immediate
treatment with airway
management,
epinephrine, o2 and IV
streroids
• Overdose may cause
Nausea, diarrhea, and
dizziness. If an overdose
occurs stop drugs and
treat supportively until
drug has been eliminated
from the body
Omeprazole
C- Antacid
• Pathologic
47
hypersecretory
conditions
• Duodenal ulcer
• Heartburn
• Posterior laryngitis
H–
Patient is free from gastric
discomfort
E - 40 mg, IVTT, OD
K-
47
• Advise patient that OTC
isn’t intended for
immediate relieve of
heartburn
• Lower doses aren’t
needed for patients with
renal and hepatic
impairment
• Warn patient not to chew,
crush tablets or capsules
Albumine
C- Plasma Volume
Expanders
• Hypovelemic shock
• hypotrotenemia
• hyperbilurubinemia
H-
(-) Hyponatremia
(-) Hypovolemia
(-) Hyperbilirubinemia
K–
• monitor fluid intake and
output, protein,
47
electrolyte, hgb, hct
levels
• Monitor patients blood
pressure often during
therapy
• If hypotension occurs
slow and stop infusion
• Tell patient report chills,
fever, dyspnea, nausea
and rash immediately
Hydrocortisone
C – glucocorticoids
• Treatment of primary
or secondary adrenal
cortex insufficiency,
rheumatic disorders,
collagen disease,
allergic states,
respiratory disease,
allergic and
inflammatory
ophthalmic
processes.Constipation
H–
(-) Inflammation
(-) Respiratory Distress
Relieve from
Hypoglycemia
47
E - 200 mg, IVTT, STAT
• K - Monitor patient’s
weight, BP, and
electrolyte levels
• Monitor patient for
stress, fever, trauma,
surgery may increase
adrenal insufficiency
• Be alert for adverse
reactions and drug
interactions
• Notify prescriber about
adverse reactions
• Instruct patient to carry
or wear medical
identification that
identifies need for
supplemental systemic
glucocorticoid for strss
• Warn patient about easy
bruising
Tell patient not to abruptly
stop taking the drug
47
without prescriber’s
consent
Nitroglycerin
C – Vasodilator
Angina Pectoris
E - 5 mg, transdermal,
STAT
K–
• Assess the patient’s
condition before starting
drug therapy and to
monitor drug
effectiveness
• Tell patient that abruptly
stopping the drug causes
coronary vasospasm
• Instruct patient to use
caution when wearing
transdermal patch near
microwave oven leaking
radiation may heat
metallic backing of patch
47
and cause burns
• If drug is ineffective
immediately notify
prescriber and keep
patient at rest
• Tell patient how to use
prescribe form of drug
• Apply transdermal forms
to any non hairy areas
except lower parts of
arms and legs to promote
maximum
Salbutamol
C – Bronchodilator
• Broncho spasm
H–
(-) wheezing
(-) dyspnea
E- ½ nebule, steam
inhalation, q4
K–
• contraindicated to
patient hypersensitive
47
to drug
• use cautiously in patient
CV disorders,
hyperthyroidism, DM
• obtain baseline data of
patient respiratory status
and assess patient often
during therapy
• If more than 1 dose is
ordered wait at least two
minutes between
nebulized doses. If
corticosteroid inhaler is
used, first have patient
use bronchodilator wait
5 minutes, and then
have patient use
corticosteroid inhaler.
This permits
bronchodilator to open
air passages for
maximum effectiveness.
47